FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation
Clinical trial NCT03584711 · COMPLETED
Trial details
- NCT number
- NCT03584711
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2025-03-30
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.